Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
Francis M DijkstraRob G J A ZuikerPieter S SiebengaRichard A Leigh-PembertonLei SunJoan D ManthisMarieke L de KamRichard LinLisa L von MoltkeDavid RezendesJoop M A van GervenPublished in: British journal of clinical pharmacology (2022)
In line with ALKS 7119's in vitro pharmacological profile, the clinical profile observed in this study is most comparable to SERT inhibition.